Mexico Fusion Biopsy Market Size & Outlook, 2023-2030

The fusion biopsy market in Mexico is expected to reach a projected revenue of US$ 18.4 million by 2030. A compound annual growth rate of 9.4% is expected of Mexico fusion biopsy market from 2024 to 2030.
Revenue, 2023 (US$M)
$9.8
Forecast, 2030 (US$M)
$18.4
CAGR, 2024 - 2030
9.4%
Report Coverage
Mexico

Mexico fusion biopsy market highlights

  • The Mexico fusion biopsy market generated a revenue of USD 9.8 million in 2023 and is expected to reach USD 18.4 million by 2030.
  • The Mexico market is expected to grow at a CAGR of 9.4% from 2024 to 2030.
  • In terms of segment, transrectal was the largest revenue generating biopsy route in 2023.
  • Transperineal is the most lucrative biopsy route segment registering the fastest growth during the forecast period.


Fusion biopsy market data book summary

Market revenue in 2023USD 9.8 million
Market revenue in 2030USD 18.4 million
Growth rate9.4% (CAGR from 2023 to 2030)
Largest segmentTransrectal
Fastest growing segmentTransperineal
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationTransrectal, Transperineal
Key market players worldwideKoninklijke Philips NV, Hitachi Ltd, Esaote, Eigen, MedCom, Koelis, Focal Healthcare, UC Care


Other key industry trends

  • In terms of revenue, Mexico accounted for 1.6% of the global fusion biopsy market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil fusion biopsy market is projected to lead the regional market in terms of revenue in 2030.
  • Brazil is the fastest growing regional market in Latin America and is projected to reach USD 25.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Fusion Biopsy Market Companies

Name Profile # Employees HQ Website

Mexico fusion biopsy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fusion biopsy market will help companies and investors design strategic landscapes.


Transrectal was the largest segment with a revenue share of 85.71% in 2023. Horizon Databook has segmented the Mexico fusion biopsy market based on transrectal, transperineal covering the revenue growth of each sub-segment from 2018 to 2030.


Private healthcare services provider in Mexico dominate the healthcare industry. As of 2013, Mexico had over 4,466 hospitals, of which, around 67.0% are private and the remaining 33.0% are government hospitals. Mexico is one of the major exporters of medical products to North America and Europe. This offers significant growth opportunities for companies operating in Mexico’s fusion biopsy market.

Reasons to subscribe to Mexico fusion biopsy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Mexico fusion biopsy market databook

  • Our clientele includes a mix of fusion biopsy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Mexico fusion biopsy market , including forecasts for subscribers. This country databook contains high-level insights into Mexico fusion biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Mexico fusion biopsy market size, by biopsy route, 2018-2030 (US$M)

Mexico Fusion Biopsy Market Outlook Share, 2023 & 2030 (US$M)

Mexico fusion biopsy market size, by biopsy route, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more